U.S. Selected Practice Recommendations for Contraceptive Use, 2016.

The 2016 U.S. Selected Practice Recommendations for Contraceptive Use (U.S. SPR) addresses a select group of common, yet sometimes controversial or complex, issues regarding initiation and use of specific contraceptive methods. These recommendations for health care providers were updated by CDC after review of the scientific evidence and consultation with national experts who met in Atlanta, Georgia, during August 26-28, 2015. The information in this report updates the 2013 U.S. SPR (CDC. U.S. selected practice recommendations for contraceptive use, 2013. MMWR 2013;62[No. RR-5]). Major updates include 1) revised recommendations for starting regular contraception after the use of emergency contraceptive pills and 2) new recommendations for the use of medications to ease insertion of intrauterine devices. The recommendations in this report are intended to serve as a source of clinical guidance for health care providers and provide evidence-based guidance to reduce medical barriers to contraception access and use. Health care providers should always consider the individual clinical circumstances of each person seeking family planning services. This report is not intended to be a substitute for professional medical advice for individual patients. Persons should seek advice from their health care providers when considering family planning options.

[1]  J. Guillebaud,et al.  Medical eligibility criteria for contraceptive use , 2018, Advanced Health Assessment of Women.

[2]  L. Finer,et al.  Perspectives on Sexual and Reproductive Health , 2018, Perspectives on Sexual and Reproductive Health.

[3]  Melissa J. Chen,et al.  Development, updates, and future directions of the World Health Organization Selected Practice Recommendations for Contraceptive Use , 2016, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[4]  K. Curtis,et al.  Medications to ease intrauterine device insertion: a systematic review. , 2016, Contraception.

[5]  K. Curtis,et al.  Safety and effectiveness data for emergency contraceptive pills among women with obesity: a systematic review. , 2016, Contraception.

[6]  K. Curtis,et al.  The safety of intrauterine contraception initiation among women with current asymptomatic cervical infections or at increased risk of sexually transmitted infections. , 2016, Contraception.

[7]  K. Curtis,et al.  Research gaps from evidence-based contraception guidance: the US Medical Eligibility Criteria for Contraceptive Use, 2016, and the US Selected Practice Recommendations for Contraceptive Use, 2016. , 2016, Contraception.

[8]  K. Curtis,et al.  Safety of intrauterine devices among women with HIV: a systematic review. , 2016, Contraception.

[9]  K. Curtis,et al.  Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes. , 2016, Contraception.

[10]  S. Kochhar.  UK medical eligibility criteria for contraceptive use , 2016 .

[11]  T. Lawrie,et al.  Techniques for the interruption of tubal patency for female sterilisation. , 2016, The Cochrane database of systematic reviews.

[12]  K. Curtis,et al.  U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. , 2016, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[13]  L. Finer,et al.  Declines in Unintended Pregnancy in the United States, 2008-2011. , 2016, The New England journal of medicine.

[14]  N. Kapp,et al.  A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception. , 2015, Human reproduction.

[15]  L. Bahamondes,et al.  Effect of vaginal administration of misoprostol before intrauterine contraceptive insertion following previous insertion failure: a double blind RCT. , 2015, Human reproduction.

[16]  L. Lopez,et al.  Interventions for pain with intrauterine device insertion. , 2015, The Cochrane database of systematic reviews.

[17]  K. Gemzell‐Danielsson,et al.  The effects on ovarian activity of ulipristal acetate when 'quickstarting' a combined oral contraceptive pill: a prospective, randomized, double-blind parallel-arm, placebo-controlled study. , 2015, Human reproduction.

[18]  N. Tumwesigye,et al.  Clinical versus laboratory screening for sexually transmitted infections prior to insertion of intrauterine contraception among women living with HIV/AIDS: a randomized controlled trial. , 2015, Human reproduction.

[19]  K. Workowski,et al.  Sexually transmitted diseases treatment guidelines, 2015. , 2015, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[20]  J. Peipert,et al.  Positive Testing for Neisseria gonorrhoeae and Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease in IUD Users. , 2015, Journal of women's health.

[21]  Kevin A. Henry,et al.  Annual Report to the Nation on the Status of Cancer, 1975–2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State , 2015, Journal of the National Cancer Institute.

[22]  K. Schulz,et al.  Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus. , 2014, The Cochrane database of systematic reviews.

[23]  K. Curtis,et al.  Providing quality family planning services: Recommendations of CDC and the U.S. Office of Population Affairs. , 2014, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[24]  I. Hoffman,et al.  Contraceptive adherence among HIV-infected women in Malawi: a randomized controlled trial of the copper intrauterine device and depot medroxyprogesterone acetate. , 2013, Contraception.

[25]  K. Agnew,et al.  Effect of the Levonorgestrel Intrauterine Device on Genital HIV-1 RNA Shedding Among HIV-1–Infected Women Not Taking Antiretroviral Therapy in Nairobi, Kenya , 2013, Journal of acquired immune deficiency syndromes.

[26]  J. Ananworanich,et al.  Uptake and continuous use of copper intrauterine device in a cohort of HIV-positive women , 2013, AIDS care.

[27]  K. Curtis,et al.  When can a woman start combined hormonal contraceptives (CHCs)? A systematic review. , 2013, Contraception.

[28]  Maria I. Rodriguez,et al.  Prevention and management of nausea and vomiting with emergency contraception: a systematic review. , 2013, Contraception.

[29]  K. Curtis,et al.  When can a woman have an intrauterine device inserted? A systematic review. , 2013, Contraception.

[30]  K. Curtis,et al.  Physical examination prior to initiating hormonal contraception: a systematic review. , 2013, Contraception.

[31]  Maria I. Rodriguez,et al.  When can a woman resume or initiate contraception after taking emergency contraceptive pills? A systematic review. , 2013, Contraception.

[32]  K. Curtis,et al.  Use of a checklist to rule out pregnancy: a systematic review. , 2013, Contraception.

[33]  K. Curtis,et al.  Appropriate follow up to detect potential adverse events after initiation of select contraceptive methods: a systematic review. , 2013, Contraception.

[34]  K. Curtis,et al.  Effect of missed combined hormonal contraceptives on contraceptive effectiveness: a systematic review. , 2013, Contraception.

[35]  K. Curtis,et al.  Blood pressure measurement prior to initiating hormonal contraception: a systematic review. , 2013, Contraception.

[36]  K. Curtis,et al.  Treatment of unscheduled bleeding in women using extended- or continuous-use combined hormonal contraception: a systematic review. , 2013, Contraception.

[37]  Maria I. Rodriguez,et al.  Advance supply of emergency contraception: a systematic review. , 2013, Contraception.

[38]  Maria I. Rodriguez,et al.  How does the number of oral contraceptive pill packs dispensed or prescribed affect continuation and other measures of consistent and correct use? A systematic review. , 2013, Contraception.

[39]  K. Curtis,et al.  Pregnancies after hysteroscopic sterilization: a systematic review. , 2013, Contraception.

[40]  K. Curtis,et al.  Hemoglobin measurement prior to initiating copper intrauterine devices: a systematic review. , 2013, Contraception.

[41]  K. Curtis,et al.  Laboratory screening prior to initiating contraception: a systematic review. , 2013, Contraception.

[42]  K. Curtis,et al.  Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review. , 2013, Contraception.

[43]  N. Kapp,et al.  Initiation of progestogen-only injectables on different days of the menstrual cycle and its effect on contraceptive effectiveness and compliance: a systematic review. , 2013, Contraception.

[44]  K. Curtis,et al.  The effect of follow-up visits or contacts after contraceptive initiation on method continuation and correct use. , 2013, Contraception.

[45]  K. Curtis,et al.  Treatment of bleeding irregularities in women with copper-containing IUDs: a systematic review. , 2013, Contraception.

[46]  J. Steinauer,et al.  Neisseria gonorrhea and Chlamydia trachomatis Screening at Intrauterine Device Insertion and Pelvic Inflammatory Disease , 2012, Obstetrics and gynecology.

[47]  J. Trussell,et al.  The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. , 2012, Human reproduction.

[48]  I. Sinai,et al.  Contraceptive failure in the United States. , 2012, Contraception.

[49]  K. Curtis,et al.  Pregnancy outcomes with an IUD in situ: a systematic review. , 2012, Contraception.

[50]  X. Deffieux,et al.  3D ultrasound to assess the position of tubal sterilization microinserts. , 2011, Human reproduction.

[51]  A. Rademaker,et al.  Pain control for intrauterine device insertion: a randomized trial of 1% lidocaine paracervical block. , 2011, Contraception.

[52]  C. Westhoff,et al.  The Effect of Pack Supply on Oral Contraceptive Pill Continuation: A Randomized Controlled Trial , 2011, Obstetrics and gynecology.

[53]  D. Eisenberg,et al.  Controversies in family planning: timing of ovulation after abortion and the conundrum of postabortion intrauterine device insertion. , 2011, Contraception.

[54]  N. Sänger,et al.  Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy. , 2011, Contraception.

[55]  G. Piaggio,et al.  Effect on pregnancy rates of the delay in the administration of levonorgestrel for emergency contraception: a combined analysis of four WHO trials. , 2011, Contraception.

[56]  S. Christin‐Maitre,et al.  Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17β-estradiol (NOMAC/E2): a double-blind, randomized study. , 2011, Human reproduction.

[57]  M. Secic,et al.  Early Weight Gain Related to Later Weight Gain in Adolescents on Depot Medroxyprogesterone Acetate , 2011, Obstetrics and gynecology.

[58]  A. Glasier,et al.  Return of Ovulation and Menses in Postpartum Nonlactating Women: A Systematic Review , 2011, Obstetrics and gynecology.

[59]  J. Paavonen,et al.  The levonorgestrel-releasing intrauterine system in human immunodeficiency virus-infected women: a 5-year follow-up study. , 2011, American journal of obstetrics and gynecology.

[60]  E. Gratacós,et al.  Delayed Childbearing: Effects on Fertility and the Outcome of Pregnancy , 2011, Fetal Diagnosis and Therapy.

[61]  J. Dinger,et al.  Effectiveness of Oral Contraceptive Pills in a Large U.S. Cohort Comparing Progestogen and Regimen , 2011, Obstetrics and gynecology.

[62]  C. Westhoff,et al.  Vaginal estrogen supplementation during Depo-Provera initiation: a randomized controlled trial. , 2010, Contraception.

[63]  P. Darney,et al.  Number of Oral Contraceptive Pill Packages Dispensed and Subsequent Unintended Pregnancies , 2010, Obstetrics and gynecology.

[64]  B. Kaneshiro,et al.  Treatment of Unscheduled Bleeding in Continuous Oral Contraceptive Users With Doxycycline: A Randomized Controlled Trial , 2010, Obstetrics and gynecology.

[65]  B. Dilbaz,et al.  Effect of etonogestrel implant on serum lipids, liver function tests and hemoglobin levels. , 2010, Contraception.

[66]  J. Stanback,et al.  Excluding pregnancy among women initiating antiretroviral therapy: efficacy of a family planning job aid , 2010, BMC public health.

[67]  K. Cropsey,et al.  Long-term, reversible contraception use among high-risk women treated in a university-based gynecology clinic: comparison between IUD and depo-provera. , 2010, Journal of women's health.

[68]  Johanna Morfesis,et al.  Ulipristal Acetate Taken 48–120 Hours After Intercourse for Emergency Contraception , 2010, Obstetrics and gynecology.

[69]  M. Zarchi,et al.  Assessment of two emergency contraceptive regimens in Iran: levonorgestrel versus the Yuzpe. , 2009, Nigerian journal of clinical practice.

[70]  L. Cole.  Human chorionic gonadotropin tests , 2009, Expert review of molecular diagnostics.

[71]  K. Curtis,et al.  When can a woman have repeat progestogen-only injectables--depot medroxyprogesterone acetate or norethisterone enantate? , 2009, Contraception.

[72]  K. Curtis,et al.  Hormonal contraceptive use among women with liver tumors: a systematic review. , 2009, Contraception.

[73]  K. Curtis,et al.  The effects of hormonal contraceptive use among women with viral hepatitis or cirrhosis of the liver: a systematic review. , 2009, Contraception.

[74]  Mahbubur Rahman,et al.  Effect of Injectable and Oral Contraceptives on Serum Lipids , 2009, Obstetrics and gynecology.

[75]  E. Løkkegaard,et al.  Hormonal contraception and risk of venous thromboembolism: national follow-up study , 2009, BMJ : British Medical Journal.

[76]  F. Broekmans,et al.  Ovarian aging: mechanisms and clinical consequences. , 2009, Endocrine reviews.

[77]  I. Fraser,et al.  A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users. , 2009, Human reproduction.

[78]  Mahbubur Rahman,et al.  Early Weight Gain Predicting Later Weight Gain Among Depot Medroxyprogesterone Acetate Users , 2009, Obstetrics and gynecology.

[79]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[80]  B. Chi,et al.  HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial , 2009, AIDS.

[81]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, BMJ : British Medical Journal.

[82]  P. Panel,et al.  [Essure implants for tubal sterilisation in France]. , 2009, Gynecologie, obstetrique & fertilite.

[83]  C. Morrison,et al.  Highly effective contraception and acquisition of HIV and other sexually transmitted infections. , 2009, Best practice & research. Clinical obstetrics & gynaecology.

[84]  M. Diamond,et al.  Placement of a permanent birth control device at a university medical center. , 2009, The Journal of reproductive medicine.

[85]  S. Taneepanichskul,et al.  Efficacy of celecoxib on controlling irregular uterine bleeding secondary to Jadelle use. , 2009, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[86]  F. Byrn,et al.  The normal variabilities of the menstrual cycle. , 2009, Fertility and sterility.

[87]  W. Savage.  Guidelines for Women's Health Care. A Resource Manual 3rd Edition , 2009 .

[88]  S. Coughlin,et al.  Burden of cervical cancer in the United States, 1998–2003 , 2008, Cancer.

[89]  C. Castelo-Branco,et al.  Satisfaction and tolerance with office hysteroscopic tubal sterilization. , 2008, Fertility and sterility.

[90]  T. Kuehl,et al.  Frequency and Management of Breakthrough Bleeding With Continuous Use of the Transvaginal Contraceptive Ring: A Randomized Controlled Trial , 2008, Obstetrics and gynecology.

[91]  D. Mishell,et al.  Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20 mcg ethinyl estradiol and 1 mg norethindrone acetate. , 2008, Contraception.

[92]  D. Archer,et al.  Effects of ethinyl estradiol and ibuprofen compared to placebo on endometrial bleeding, cervical mucus and the postcoital test in levonorgestrel subcutaneous implant users. , 2008, Contraception.

[93]  C. Klipping,et al.  Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen. , 2008, Contraception.

[94]  C. Morrison,et al.  Injectable contraception: what should the longest interval be for reinjections? , 2008, Contraception.

[95]  M. Hindin,et al.  The effects of unintended pregnancy on infant, child, and parental health: a review of the literature. , 2008, Studies in family planning.

[96]  J. Stanback,et al.  Validation of a job aid to rule out pregnancy among family planning clients in Nicaragua. , 2008, Revista panamericana de salud publica = Pan American journal of public health.

[97]  I. Fraser,et al.  The effects of Implanon® on menstrual bleeding patterns , 2008, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[98]  G. Melnichenko,et al.  Use of the NuvaRing® hormone-releasing system in late reproductive-age women with type 1 diabetes mellitus , 2008, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[99]  U. Karck,et al.  Cycle control, tolerability, efficacy and acceptability of the vaginal contraceptive ring, NuvaRing®: Results of clinical experience in Germany , 2008, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[100]  I. Greer,et al.  Is screening for thrombophilia cost-effective? , 2007, Current opinion in hematology.

[101]  B. Chi,et al.  A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. , 2007, American journal of obstetrics and gynecology.

[102]  K. Cropsey,et al.  Intrauterine device use in a high-risk population: experience from an urban university clinic. , 2007, American journal of obstetrics and gynecology.

[103]  I. Blickstein,et al.  Oral contraception and thrombophilia , 2007, Current opinion in obstetrics & gynecology.

[104]  Jeffrey A. Feinstein,et al.  Noninherited Risk Factors and Congenital Cardiovascular Defects: Current Knowledge: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young , 2007, Circulation.

[105]  G. Stuart,et al.  Initiation of Oral Contraceptives Using a Quick Start Compared With a Conventional Start: A Randomized Controlled Trial , 2007, Obstetrics and gynecology.

[106]  B. Levy,et al.  A summary of reported pregnancies after hysteroscopic sterilization. , 2007, Journal of minimally invasive gynecology.

[107]  J. Jones,et al.  A prospective evaluation of the impact of scheduled follow‐up appointments with compliance rates after vasectomy , 2007, BJU international.

[108]  F. Skjeldestad,et al.  A randomized trial on the clinical performance of Nova T®380 and Gyne T®380 Slimline copper IUDs ☆ , 2007 .

[109]  C. Westhoff,et al.  Initiation of oral contraceptives--start now! , 2007, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[110]  A. Nelson,et al.  Initiation and continuation rates seen in 2-year experience with Same Day injections of DMPA. , 2007, Contraception.

[111]  I. Milsom,et al.  Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. , 2006, Contraception.

[112]  J. Paavonen,et al.  The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women--effects on bleeding patterns, ovarian function and genital shedding of HIV. , 2006, Human reproduction.

[113]  P. Darney,et al.  Number of Oral Contraceptive Pill Packages Dispensed, Method Continuation, and Costs , 2006, Obstetrics and gynecology.

[114]  R. Frezieres,et al.  Progesterone Receptor Modulator for Emergency Contraception: A Randomized Controlled Trial , 2006, Obstetrics and gynecology.

[115]  L. Bernstein,et al.  Oral contraceptive use and risk of breast carcinoma in situ (United States) , 2006, Cancer Causes & Control.

[116]  T. Kuehl,et al.  Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen. , 2006, American journal of obstetrics and gynecology.

[117]  M. Labrecque,et al.  Frequency and patterns of early recanalization after vasectomy , 2006, BMC urology.

[118]  C. Brucker,et al.  Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg. , 2006, Contraception.

[119]  A. Spiekerman,et al.  Greater inhibition of the pituitary--ovarian axis in oral contraceptive regimens with a shortened hormone-free interval. , 2006, Contraception.

[120]  S. Taneepanichskul,et al.  Efficacy of a selective COX-2 inhibitor for controlling irregular uterine bleeding in DMPA users. , 2006, Contraception.

[121]  B. Janowitz,et al.  Over-the-counter pill provision: evidence from Jamaica. , 2006, Studies in family planning.

[122]  S. Chudnoff,et al.  Prospective analysis of office-based hysteroscopic sterilization. , 2006, Journal of minimally invasive gynecology.

[123]  M Greaves,et al.  Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. , 2006, Health technology assessment.

[124]  A. Sophonsritsuk,et al.  The effect of tranexamic acid for treatment of irregular uterine bleeding secondary to Norplant use. , 2006, Contraception.

[125]  L. Simpson,et al.  Higher rate of stillbirth at the extremes of reproductive age: a large nationwide sample of deliveries in the United States. , 2006, American journal of obstetrics and gynecology.

[126]  K. Curtis,et al.  Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review. , 2006, Contraception.

[127]  K. Curtis,et al.  Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review. , 2006, Contraception.

[128]  Z. Qureshi,et al.  Does assessment of signs and symptoms add to the predictive value of an algorithm to rule out pregnancy? , 2006, Journal of Family Planning and Reproductive Health Care.

[129]  O. Shaaban,et al.  Tamoxifen treatment of bleeding irregularities associated with Norplant use. , 2005, Contraception.

[130]  S. Duffy,et al.  Female sterilisation: a cohort controlled comparative study of ESSURE versus laparoscopic sterilisation , 2005, BJOG : an international journal of obstetrics and gynaecology.

[131]  M. Creinin,et al.  Same-day initiation of the transdermal hormonal delivery system (contraceptive patch) versus traditional initiation methods. , 2005, Contraception.

[132]  C. Morroni,et al.  Bleeding Patterns After Immediate Initiation of an Oral Compared With a Vaginal Hormonal Contraceptive , 2005, Obstetrics and gynecology.

[133]  K. Curtis,et al.  Keeping up with evidence a new system for WHO's evidence-based family planning guidance. , 2005, American journal of preventive medicine.

[134]  C. Klipping,et al.  Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism. , 2005, Contraception.

[135]  J. Balkus,et al.  Same-day administration of depot-medroxyprogesterone acetate injection: a retrospective chart review. , 2005, Contraception.

[136]  Pai-Lien Chen,et al.  Effect of a Levonorgestrel Intrauterine System on Women With Type 1 Diabetes: A Randomized Trial , 2005, Obstetrics and gynecology.

[137]  C. Morroni,et al.  A prospective study of immediate initiation of depo medroxyprogesterone acetate contraceptive injection. , 2005, Contraception.

[138]  A. Zini,et al.  Vasectomy follow-up: clinical significance of rare nonmotile sperm in postoperative semen analysis. , 2004, Urology.

[139]  G. Piaggio,et al.  Effectiveness and acceptability of vitamin E and low-dose aspirin, alone or in combination, on Norplant-induced prolonged bleeding. , 2004, Contraception.

[140]  C. Verhoeven,et al.  Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study. , 2004, Human reproduction.

[141]  F. Bode,et al.  Suppression of ovulation by a new subcutaneous depot medroxyprogesterone acetate (104 mg/0.65 mL) contraceptive formulation in Asian women. , 2004, Clinical therapeutics.

[142]  R. Pierson,et al.  Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use. , 2004, Contraception.

[143]  S. Taneepanichskul,et al.  Effect of mefenamic acid on controlling irregular uterine bleeding in DMPA users. , 2004, Contraception.

[144]  S. Taneepanichskul,et al.  The effect of mefenamic acid on controlling irregular uterine bleeding second to Implanon use. , 2004, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[145]  Jeannine S. Schiller,et al.  Summary health statistics for U.S. adults: National Health Interview Survey, 2002. , 2004, Vital and health statistics. Series 10, Data from the National Health Survey.

[146]  D. Mishell,et al.  Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera. , 2004, Contraception.

[147]  C. Morroni,et al.  Immediate monthly combination contraception to facilitate initiation of the depot medroxyprogesterone acetate contraceptive injection. , 2004, Contraception.

[148]  J. Endrikat,et al.  Plasma concentrations of endogenous hormones during one regular treatment cycle with a low-dose oral contraceptive and during two cycles with deliberate omission of two tablets , 2004, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[149]  M. Cedars,et al.  Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression. , 2004, American journal of obstetrics and gynecology.

[150]  S. Eichner,et al.  Urinary-Based Ovulation and Pregnancy: Point-of-Care Testing , 2004, The Annals of pharmacotherapy.

[151]  A. Di Spiezio Sardo,et al.  Effectiveness and mechanism of action of desmopressin in the treatment of copper intrauterine device-related menorrhagia: a pilot study. , 2003, Human reproduction.

[152]  R. Pierson,et al.  Ortho Evra/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error. , 2003, Fertility and sterility.

[153]  J. Trussell,et al.  Extending the Time Limit for Starting the Yuzpe Regimen of Emergency Contraception to 120 Hours , 2003, Obstetrics and gynecology.

[154]  U. Jaisamrarn,et al.  A randomized trial on the impact of starting day on ovarian follicular activity in very low dose oral contraceptive pills users. , 2003, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[155]  S. Altunyurt,et al.  A randomized controlled trial of coil removal prior to treatment of pelvic inflammatory disease. , 2003, European journal of obstetrics, gynecology, and reproductive biology.

[156]  C. Morroni,et al.  Bleeding patterns after immediate vs. conventional oral contraceptive initiation: a randomized, controlled trial. , 2003, Fertility and sterility.

[157]  Ronald E. Ragan,et al.  Metoclopramide pretreatment attenuates emergency contraceptive-associated nausea. , 2003, American journal of obstetrics and gynecology.

[158]  V. Fortin,et al.  Effectiveness and complications associated with 2 vasectomy occlusion techniques. , 2002, The Journal of urology.

[159]  B. Friedenson.  Oral contraceptives and the risk of breast cancer. , 2002, The New England journal of medicine.

[160]  A. Arowojolu,et al.  Comparative evaluation of the effectiveness and safety of two regimens of levonorgestrel for emergency contraception in Nigerians. , 2002, Contraception.

[161]  H. Bennink,et al.  Ovarian function with a novel combined contraceptive vaginal ring. , 2002, Human reproduction.

[162]  M. Creinin,et al.  The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 μg ethinyl estradiol versus monophasic levonorgestrel/20 μg ethinyl estradiol , 2002 .

[163]  Jennifer Kerns,et al.  Quick start: novel oral contraceptive initiation method. , 2002, Contraception.

[164]  D. Apter,et al.  Efficacy, Cycle Control, and User Acceptability of a Novel Combined Contraceptive Vaginal Ring , 2002, Obstetrics and gynecology.

[165]  E. Lara-Torre,et al.  Adolescent compliance and side effects with Quick Start initiation of oral contraceptive pills. , 2002, Contraception.

[166]  T. Black,et al.  The evolution of the Marie Stopes electrocautery no-scalpel vasectomy procedure , 2002, Journal of Family Planning and Reproductive Health Care.

[167]  Irit Sinai,et al.  Efficacy of a new method of family planning: the Standard Days Method. , 2002, Contraception.

[168]  P. Pearson,et al.  The variability of female reproductive ageing. , 2002, Human reproduction update.

[169]  H. Adami,et al.  Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[170]  M. Tuppurainen,et al.  Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol. , 2002, American journal of obstetrics and gynecology.

[171]  J. Schwartz,et al.  Predicting Risk of Ovulation in New Start Oral Contraceptive Users , 2002, Obstetrics and gynecology.

[172]  L. Bahamondes,et al.  Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. , 2002, Contraception.

[173]  J. Natarajan,et al.  Pharmacokinetics of Norelgestromin and Ethinyl Estradiol Delivered by a Contraceptive Patch (Ortho Evra™/Evra™) under Conditions of Heat, Humidity, and Exercise , 2001, Journal of clinical pharmacology.

[174]  Mardge H. Cohen,et al.  Determinants of HIV-1 shedding in the genital tract of women , 2001, The Lancet.

[175]  D. Dunson,et al.  Natural limits of pregnancy testing in relation to the expected menstrual period. , 2001, JAMA.

[176]  F. Biro,et al.  Supplementation with vitamin C and/or vitamin B(6) in the prevention of Depo-Provera side effects in adolescents. , 2001, Journal of pediatric and adolescent gynecology.

[177]  C. Morrison,et al.  Is the intrauterine device appropriate contraception for HIV‐1‐infected women? , 2001 .

[178]  C. Harper,et al.  Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence. , 2001, JAMA.

[179]  T M Mulders,et al.  Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition. , 2001, Fertility and sterility.

[180]  D. Dunson,et al.  Likelihood of conception with a single act of intercourse: providing benchmark rates for assessment of post-coital contraceptives. , 2001, Contraception.

[181]  J. Joly,et al.  Effectiveness of emergency contraceptive pills between 72 and 120 hours after unprotected sexual intercourse. , 2001, American journal of obstetrics and gynecology.

[182]  M. Luna,et al.  Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate. , 2001, Contraception.

[183]  D D Baird,et al.  The timing of the “fertile window” in the menstrual cycle: day specific estimates from a prospective study , 2000, BMJ : British Medical Journal.

[184]  A. Glasier,et al.  Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel. , 2000, Human reproduction.

[185]  B. Affandi,et al.  Benefits of vitamin E supplementation to Norplant users--in vitro and in vivo studies. , 2000, Toxicology.

[186]  R. Troisi,et al.  Oral contraceptive use and glucose metabolism in a national sample of women in the united states. , 2000, American journal of obstetrics and gynecology.

[187]  S. Shapiro,et al.  Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives. , 2000, American journal of epidemiology.

[188]  M. Zaki,et al.  Contraception in Diabetic Women: Comparative Metabolic Study of Norplant, Depot Medroxyprogesterone Acetate, Low Dose Oral Contraceptive Pill and CuT380A , 2000, The journal of obstetrics and gynaecology research.

[189]  K. Barnhart,et al.  Meclizine for Prevention of Nausea Associated With Use of Emergency Contraceptive Pills: A Randomized Trial , 2000, Obstetrics and gynecology.

[190]  I. Sinai,et al.  A fixed formula to define the fertile window of the menstrual cycle as the basis of a simple method of natural family planning. , 1999, Contraception.

[191]  P. Lähteenmäki,et al.  Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment. , 1999, Contraception.

[192]  C. Morrison,et al.  Effect of intrauterine device use on cervical shedding of HIV-1 DNA. , 1999, AIDS.

[193]  J. Fortney,et al.  Follow-up visits after IUD insertion. Are more better? , 1999, The Journal of reproductive medicine.

[194]  C. Sekadde-kigondu,et al.  Checklist for ruling out pregnancy among family-planning clients in primary care , 1999, The Lancet.

[195]  K. Schulz,et al.  Prophylactic antibiotics for intrauterine device insertion: a metaanalysis of the randomized controlled trials. , 1999, Contraception.

[196]  E. O. Hassan,et al.  The effect of 1-year use of the CuT 380A and oral contraceptive pills on hemoglobin and ferritin levels. , 1999, Contraception.

[197]  K. Schulz,et al.  Antibiotic prophylaxis for intrauterine contraceptive device insertion. , 1999, The Cochrane database of systematic reviews.

[198]  M. Elstein,et al.  Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activity , 1999 .

[199]  M. Thorogood,et al.  Oral contraceptives and myocardial infarction: results of the MICA case-control study , 1999, BMJ.

[200]  W. Risser,et al.  Weight change in adolescents who used hormonal contraception. , 1999, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[201]  L. Bahamondes,et al.  Timing of onset of contraceptive effectiveness in Depo-Provera users. II. Effects on ovarian function. , 1998, Fertility and sterility.

[202]  Z. Ben-Rafael,et al.  Flexible starting schedule for oral contraception: effect on the incidence of breakthrough bleeding and compliance. , 1998, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[203]  M. Labrecque,et al.  [Efficacy and complications associated with vasectomies in two clinics in the Quebec region]. , 1998, Canadian family physician Medecin de famille canadien.

[204]  B. Henderson,et al.  Use of oral contraceptives and risk of breast cancer in young women , 1998, Breast Cancer Research and Treatment.

[205]  J. Deprest,et al.  Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation. , 1998, American journal of obstetrics and gynecology.

[206]  C. Morrison,et al.  Complications of use of intrauterine devices among HIV-1-infected women , 1998, The Lancet.

[207]  L. Bahamondes,et al.  Timing of onset of contraceptive effectiveness in Depo-Provera users: Part I. Changes in cervical mucus. , 1998, Fertility and sterility.

[208]  B. Chohan,et al.  Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina , 1997, The Lancet.

[209]  T. Maatman,et al.  Patient noncompliance after vasectomy. , 1997, Fertility and sterility.

[210]  W. Spitzer,et al.  The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women. , 1997, Contraception.

[211]  P. Rogers,et al.  Oestrogen treatment for increased bleeding in Norplant users: preliminary results. , 1996, Human reproduction.

[212]  A. Pinol,et al.  Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction , 1996, Human reproduction.

[213]  W. Willett,et al.  Recent oral contraceptive use and risk of breast cancer (United States) , 1996, Cancer Causes & Control.

[214]  A. Kauschansky,et al.  A delayed starting schedule of oral contraception: the effect on the incidence of breakthrough bleeding and compliance in women. , 1996, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[215]  W. Feichtinger,et al.  Shorter pill-free interval in combined oral contraceptives decreases follicular development. , 1996, Contraception.

[216]  Julian Peto,et al.  Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies , 1996, The Lancet.

[217]  Qiao-zhi Yang,et al.  Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception. , 1996, Contraception.

[218]  J. Trussell,et al.  The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. , 1996, American journal of obstetrics and gynecology.

[219]  A. Faúndes,et al.  Hormonal treatment for bleeding irregularities in Norplant implant users. , 1996, American journal of obstetrics and gynecology.

[220]  I. Milsom,et al.  The influence of the Gyne-T 380S IUD on menstrual blood loss and iron status. , 1995, Contraception.

[221]  M. McCann,et al.  Progestin-only oral contraception: a comprehensive review. , 1994, Contraception.

[222]  H. Chase,et al.  Oral contraceptives and renal and retinal complications in young women with insulin-dependent diabetes mellitus. , 1994, JAMA.

[223]  J. Queenan,et al.  The Lactational Amenorrhea Method (LAM): A postpartum introductory family planning method with policy and program implications , 1994, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

[224]  I. Milsom,et al.  The long-term effects of copper surface area on menstrual blood loss and iron status in women fitted with an IUD. , 1993, Contraception.

[225]  P. Ho,et al.  A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception. , 1993, Human reproduction.

[226]  I. Edwards,et al.  Earlier testing after vasectomy, based on the absence of motile sperm. , 1993, Fertility and sterility.

[227]  G. Letterie,et al.  Effect of “Missed” Pills on Oral Contraceptive Effectiveness , 1992, Obstetrics and gynecology.

[228]  R. Gray,et al.  The long-term growth and development of children exposed to Depo-Provera during pregnancy or lactation. , 1992, Contraception.

[229]  T. Farley,et al.  Intrauterine devices and pelvic inflammatory disease: an international perspective , 1992, The Lancet.

[230]  R. Gray,et al.  In utero exposure to steroid contraceptives and outcome of pregnancy. , 1991, American journal of epidemiology.

[231]  R. Gray,et al.  In utero exposure to steroid contraceptives and survival during infancy. , 1991, American journal of epidemiology.

[232]  M. Blum,et al.  Ferritin, a faithful reflection of iron deficiency in IUD wearers with mild vaginal spotting , 1991, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

[233]  G. Csemiczky,et al.  The effect of follicular growth and luteal function of "missing the pill". A comparison between a monophasic and a triphasic combined oral contraceptive. , 1991, Contraception.

[234]  M. Bracken.  Oral contraception and congenital malformations in offspring: a review and meta-analysis of the prospective studies. , 1990, Obstetrics and gynecology.

[235]  M. Sexter,et al.  The high rate of noncompliance for post-vasectomy semen examination: medical and legal considerations. , 1990, The Journal of urology.

[236]  D. Cranston,et al.  The long-term outcome following "special clearance" after vasectomy. , 1990, British journal of urology.

[237]  I. Sivin,et al.  Clinical assessment of treatments for prolonged bleeding in users of Norplant implants. , 1990, Contraception.

[238]  Z. El-sheikha,et al.  Menstrual blood loss of TCu-380 A and TCu-200 B IUDs. , 1990, Population sciences.

[239]  I. Milsom,et al.  The influence of copper surface area on menstrual blood loss and iron status in women fitted with an IUD. , 1990, Contraception.

[240]  M. Elstein,et al.  Extending the duration of the pill-free interval during combined oral contraception , 1990, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

[241]  P. Piot,et al.  Incidence of Uncomplicated Genital Infections in Women Using Oral Contraception or an Intrauterine Device: A Prospective Study , 1990, Sexually transmitted diseases.

[242]  H. Hoogland,et al.  Longitudinal ultrasonographic study of the ovarian suppressive activity of a low-dose triphasic oral contraceptive during correct and incorrect pill intake. , 1989, American journal of obstetrics and gynecology.

[243]  S. Killick.  Ovarian follicles during oral contraceptive cycles: their potential for ovulation. , 1989, Fertility and sterility.

[244]  K. Kennedy,et al.  Consensus statement on the use of breastfeeding as a family planning method. , 1989, Contraception.

[245]  K. Teisala.  Removal of an intrauterine device and the treatment of acute pelvic inflammatory disease. , 1989, Annals of medicine.

[246]  P. Alderman,et al.  The lurking sperm. A review of failures in 8879 vasectomies performed by one physician. , 1988, JAMA.

[247]  Manuel Calderón Sánchez,et al.  Long-term effects of MPA on human progeny: intellectual development. , 1988, Contraception.

[248]  M. Elstein,et al.  Ovarian follicular development in oral contraceptive cycles. , 1987, Fertility and sterility.

[249]  N. Pedrón,et al.  The effect of acetylsalicylic acid on menstrual blood loss in women with IUDs. , 1987, Contraception.

[250]  M. Im,et al.  Menstrual blood loss, iron nutriture, and the effects of Alza-T IPCS 52, T-Cu 220C and Lippes Loop D in Korean women. , 1987, The Seoul journal of medicine.

[251]  D. Mishell,et al.  Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices. , 1987, Contraception.

[252]  B. Sun,et al.  Menstrual blood loss, haemoglobin and ferritin concentration of Beijing women wearing steel ring, VCu 200, and TCu 220c IUDs. , 1986, Contraception.

[253]  D. Baird,et al.  The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis. , 1986, Contraception.

[254]  D. R. Taylor,et al.  Suppression of ovarian function by Microgynon 30 in day 1 and day 5 "starters". , 1986, Contraception.

[255]  H. Timonen,et al.  Iron Deficiency in Women Using Modern Copper Intrauterine Devices , 1986, Obstetrics and gynecology.

[256]  J. Winter,et al.  Postpartum disappearance of chorionic gonadotropin from the maternal and neonatal circulations. , 1985, American journal of obstetrics and gynecology.

[257]  Y. Tayob,et al.  “Missed pill” conception: fact or fiction? , 1985, British medical journal.

[258]  I. Sivin,et al.  Intrauterine contraception with copper and with levonorgestrel: a randomized study of the TCu 380Ag and levonorgestrel 20 mcg/day devices. , 1985, Contraception.

[259]  M. Cravioto,et al.  Return to ovulation following the use of long-acting injectable contraceptives: a comparative study. , 1985, Contraception.

[260]  J. Guillebaud,et al.  Complications of vasectomy: review of 16,000 patients. , 1984, British journal of urology.

[261]  O. Myking,et al.  Human Chorionic Gonadotropin in Maternal Plasma After Induced Abortion, Spontaneous Abortion, and Removed Ectopic Pregnancy , 1984, Obstetrics and gynecology.

[262]  S. Bassol,et al.  Ovarian function following a single administration of depo-medroxyprogesterone acetate (DMPA) at different doses. , 1984, Fertility and sterility.

[263]  J. Guillebaud,et al.  Late failure of vasectomy after two documented analyses showing azoospermic semen. , 1984, British medical journal.

[264]  E. Diczfalusy,et al.  Hormonal consequences of missing the pill during the first two days of three consecutive artificial cycles. , 1984, Contraception.

[265]  T. Pardthaisong.  Return of fertility after use of the injectable contraceptive Depo Provera: up-dated data analysis , 1984, Journal of Biosocial Science.

[266]  T. H. Goh,et al.  Effect of laparoscopic sterilization and insertion of Multiload Cu 250 and Progestasert IUDs on serum ferritin levels. , 1983, Contraception.

[267]  R. Rivera,et al.  The effects of three different regimens of oral contraceptives and three different intrauterine devices on the levels of hemoglobin, serum iron and iron binding capacity in anemic women. , 1983, Contraception.

[268]  J. Garza-flores,et al.  Predictive value of serum ferritin in anemia development after insertion of T Cu 220 intrauterine device. , 1983, Contraception.

[269]  O. Ylikorkala,et al.  Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices , 1983, British journal of obstetrics and gynaecology.

[270]  E. Diczfalusy,et al.  Hormonal consequences of "missing the pill". , 1982, Contraception.

[271]  S. Leepipatpaiboon,et al.  Effect of depo-medroxyprogesterone acetate on serum progesterone levels when administered on various cycle days. , 1982, Contraception.

[272]  M. Elstein,et al.  The effect of ethinyl estradiol 20 mcg and levonorgestrel 250 mcg on the pituitary-ovarian function during normal tablet-taking and when tablets are missed. , 1982, Contraception.

[273]  N. Pedrón,et al.  Treatment of hypermenorrhea with mefenamic acid in women using IUDs. , 1982, Contraceptive delivery systems.

[274]  M. Anwar,et al.  Control of IUD-induced bleeding by three non-steroidal anti-inflammatory drugs. , 1982, Contraceptive delivery systems.

[275]  S. Shapiro,et al.  Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives. , 1981, The New England journal of medicine.

[276]  G. Söderberg,et al.  Influence of an intrauterine device on the course of an acute salpingitis. , 1981, Contraception.

[277]  E. Calzolari,et al.  [Hematological parameters and iron therapy in women with IUD's. Experimental study]. , 1981, Minerva ginecologica.

[278]  M. Mathrubutham,et al.  Pharmacokinetic study of different doses of Depo Provera. , 1980, Contraception.

[279]  C. H. Tan,et al.  A longitudinal study of serum iron indices and haemoglobin concentration following copper-IUD insertion. , 1980, Contraception.

[280]  B. Saxena,et al.  'Escape' ovulation in women due to the missing of low dose combination oral contraceptive pills. , 1980, Contraception.

[281]  E. Diczfalusy,et al.  A preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthate. , 1980, Fertility and sterility.

[282]  B. Saxena,et al.  Return of ovulation after the cessation of depot-medroxy progesterone acetate treatment in Thai women. , 1980, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[283]  J. Bedford,et al.  Viability of spermatozoa in the human ejaculate after vasectomy. , 1979, Fertility and sterility.

[284]  S. E. Morris,et al.  Studies on low dose oral contraceptives: plasma hormone changes in relation to deliberate pill ('Microgynon 30') omission. , 1979, Contraception.

[285]  P. Jouannet,et al.  Evolution of the properties of semen immediately following vasectomy. , 1978, Fertility and sterility.

[286]  R. Aznar,et al.  Intrauterine devices and menstrual blood loss. A comparative study of eight devices during the first six months of use. , 1978, Contraception.

[287]  M. Wennergren,et al.  Investigation of a copper-intrauterine device (Cu-IUD) for possible effect on frequency and healing of pelvic inflammatory disease. , 1977, Contraception.

[288]  J. Bonnar,et al.  MENSTRUAL BLOOD-LOSS WITH INTRAUTERINE DEVICES , 1976, The Lancet.

[289]  L. Hamberger,et al.  Influence of Copper Intrauterine Contraceptive Devices (Cu‐7‐Iud) on the Menstrual Blood‐Loss , 1975, Acta obstetricia et gynecologica Scandinavica.

[290]  P. C. Schwallie,et al.  The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: a review. , 1974, Contraception.

[291]  L. Bengtsson,et al.  Menstrual bleeding with copper-covered intrauterine contraceptive devices. , 1974, Contraception.

[292]  A. M. Gülmezoglu,et al.  Treatment of vaginal bleeding irregularities induced by progestin only contraceptives. , 2013, The Cochrane database of systematic reviews.

[293]  E. Taşkın,et al.  Paracervical block with 1% lidocaine for pain control during intrauterine device insertion: a prospective, single-blinded, controlled study , 2013 .

[294]  Susan J. Logan,et al.  Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis , 2011 .

[295]  H. Brölmann,et al.  Unintended pregnancies after Essure sterilization in the Netherlands. , 2010, Fertility and sterility.

[296]  A. Gronowski,et al.  Reproductive-endocrine point-of-care testing: current status and limitations , 2010, Clinical chemistry and laboratory medicine.

[297]  S. Nakajima,et al.  Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe). , 2007, Contraception.

[298]  J. Paavonen,et al.  Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women. , 2007, Contraception.

[299]  R. Vaughan,et al.  Depo Now: preventing unintended pregnancies among adolescents and young adults. , 2007, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[300]  I. Fraser,et al.  A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon. , 2006, Human reproduction.

[301]  H. Sadeghi-Bazargani,et al.  Low-dose oral contraceptive to re-induce menstrual bleeding in amenorrheic women on DMPA treatment: a randomized clinical trial. , 2006, Medical science monitor : international medical journal of experimental and clinical research.

[302]  P. Ho,et al.  A randomized trial to compare 24 h versus 12 h double dose regimen of levonorgestrel for emergency contraception. , 2005, Human reproduction.

[303]  Douglas J. Taylor,et al.  Minimum effectiveness of the levonorgestrel regimen of emergency contraception. , 2004, Contraception.

[304]  R. Pierson,et al.  Ovarian follicular development during the use of oral contraception: a review. , 2004, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[305]  K. Curtis,et al.  Effects of injectable or implantable progestin-only contraceptives on insulin-glucose metabolism and diabetes risk. , 2003, Diabetes care.

[306]  B. Ineichen,et al.  The European Journal of Contraception and Reproductive Health Care , 2002 .

[307]  Family.  Selected practice recommendations for contraceptive use , 2002 .

[308]  S. Li.  Oral contraceptives and the risk of myocardial infarction. , 2002, The New England journal of medicine.

[309]  W. Shang-chun,et al.  A Randomized Multi-center Study of Baofuxin for treatment of Bleeding side-effect induced by IUD. , 2000 .

[310]  G. Letterie.  A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation. , 1998, Contraception.

[311]  J Korhonen,et al.  Disappearance of human chorionic gonadotropin and its alpha- and beta-subunits after term pregnancy. , 1997, Clinical chemistry.

[312]  S. Shapiro,et al.  Case-control study of oral contraceptive use and risk of breast cancer. , 1996, American journal of epidemiology.

[313]  V. Odlind,et al.  Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. , 1994, Contraception.

[314]  P. Lähteenmäki,et al.  Postabortal contraception. , 1993, Annals of medicine.

[315]  P. Marés,et al.  Ovarian consequences of the transient interruption of combined oral contraceptives. , 1992, International journal of fertility.

[316]  P. Howie,et al.  Return of ovarian function following spontaneous abortion. , 1990, Clinical endocrinology.

[317]  J. W. Wood.  Fecundity and natural fertility in humans. , 1989, Oxford reviews of reproductive biology.

[318]  E. Wright,et al.  Zinc depletion and menorrhagia in Nigerians using copper T-200 intrauterine device. , 1989, Trace elements in medicine.

[319]  M. Hidalgo,et al.  [Effect of meclofenamic acid on menstruation in hypermenorrheic women using intrauterine devices]. , 1988, Revista chilena de obstetricia y ginecologia.

[320]  [Prevention and treatment of IUD-induced menorrhagia with antifibrinolytic and antiprostaglandin drugs]. , 1987, Zhonghua fu chan ke za zhi.

[321]  A. Di Lieto,et al.  Action of a prostaglandin synthetase inhibitor on IUD associated uterine bleeding. , 1987, Clinical and experimental obstetrics & gynecology.

[322]  E. Diczfalusy,et al.  Return of ovulation following a single injection of depo-medroxyprogesterone acetate: a pharmacokinetic and pharmacodynamic study. , 1984, Contraception.

[323]  M. Toppozada,et al.  Management of uterine bleeding by PGs or their synthesis inhibitors. , 1980, Advances in prostaglandin and thromboxane research.

[324]  D. Hawkins,et al.  Combined Oral Contraceptives , 1979 .

[325]  D. Mishell,et al.  Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA. , 1977, The Journal of clinical endocrinology and metabolism.

[326]  J. Palmer,et al.  American Journal of Epidemiology Original Contribution a Case-control Study of Oral Contraceptive Use and Incident Breast Cancer , 2022 .